Limits...
Goserelin (Zoladex ™ ) – its role in early breast cancer in pre- and perimenopausal women

View Article: PubMed Central

ABSTRACT

87: British Journal of Cancer (2002) , 1480–1480. doi:10.1038/sj.bjc.6600652 www.bjcancer.com

© 2002 Cancer Research UK

Correction to:85: British Journal of Cancer 2001; (Suppl 2): 1–5

No MeSH data available.


Related in: MedlinePlus

Clinical trials designs for studies involved in the evaluation of goserelin as adjuvant treatment in early breast cancer in pre-/perimenopausal patients.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2376299&req=5

fig1: Clinical trials designs for studies involved in the evaluation of goserelin as adjuvant treatment in early breast cancer in pre-/perimenopausal patients.

Mentions: An error has been noted within Figure 1Figure 1


Goserelin (Zoladex ™ ) – its role in early breast cancer in pre- and perimenopausal women
Clinical trials designs for studies involved in the evaluation of goserelin as adjuvant treatment in early breast cancer in pre-/perimenopausal patients.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2376299&req=5

fig1: Clinical trials designs for studies involved in the evaluation of goserelin as adjuvant treatment in early breast cancer in pre-/perimenopausal patients.
Mentions: An error has been noted within Figure 1Figure 1

View Article: PubMed Central

ABSTRACT

87: British Journal of Cancer (2002) , 1480–1480. doi:10.1038/sj.bjc.6600652 www.bjcancer.com

© 2002 Cancer Research UK

Correction to:85: British Journal of Cancer 2001; (Suppl 2): 1–5

No MeSH data available.


Related in: MedlinePlus